Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study

Improved Prediction of Signal Peptides: SignalP 3.0

Dyrløv Bendtsen, J., Nielsen, H., von Heijne, G., & Brunak, S. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.05.028 · Cited by 6,350 · see citing works

No adjustments are needed for multiple comparisons.

Rothman, K. J. (1990) · Epidemiology · doi:10.1097/00001648-199001000-00010 · Cited by 5,965 · see citing works

The PSIPRED protein structure prediction server

McGuffin, L. J., Bryson, K., & Jones, D. T. (2000) · Bioinformatics · doi:10.1093/bioinformatics/16.4.404 · Cited by 3,841 · see citing works

Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population.

(1995) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a040269 · Cited by 1,950 · see citing works

Atherogenesis: a postprandial phenomenon.

Zilversmit, D. B. (1979) · Circulation · doi:10.1161/01.cir.60.3.473 · Cited by 1,701 · see citing works

Combining evolutionary information and neural networks to predict protein secondary structure

Rost, B., & Sander, C. (1994) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.340190108 · Cited by 1,452 · see citing works

Genetic Data Analysis

Weir, B. S. (1990) · Cited by 1,340 · see citing works

The framingham offspring study. Design and preliminary data

Feinleib, M., Kannel, W. B., Garrison, R. J., McNamara, P. M., & Castelli, W. P. (1975) · Preventive Medicine · doi:10.1016/0091-7435(75)90037-7 · Cited by 931 · see citing works

An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing

Pennacchio, L. A., Olivier, M., Hubacek, J. A., Cohen, J. C., Cox, D. R., Fruchart, J.-C., Krauss, R. M., & Rubin, E. M. (2001) · Science · doi:10.1126/science.1064852 · Cited by 921 · see citing works

Application of multiple sequence alignment profiles to improve protein secondary structure prediction

Cuff, J. A., & Barton, G. J. (2000) · Proteins Structure Function and Bioinformatics · doi:10.1002/1097-0134(20000815)40:3 · Cited by 768 · see citing works

Development of a Proton Nuclear Magnetic Resonance Spectroscopic Method for Determining Plasma Lipoprotein Concentrations and Subspecies Distributions from a Single, Rapid Measurement

Otvos, J. D., Jeyarajah, E. J., Bennett, D. W., & Krauss, R. M. (1992) · Clinical Chemistry · doi:10.1093/clinchem/38.9.1632 · Cited by 420 · see citing works

Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels

Nakajima, K., SAITO, T., Tamura, A., Suzuki, M., Nakano, T., Adachi, M., Tanaka, A., Tada, N., Nakamura, H., Campos, E. M., et al. (1993) · Clinica Chimica Acta · doi:10.1016/0009-8981(93)90062-9 · Cited by 417 · see citing works

Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels

Pennacchio, L. A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.24.3031 · Cited by 381 · see citing works

Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides

Talmud, P. J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.24.3039 · Cited by 365 · see citing works

Postprandial lipoprotein metabolism and atherosclerosis.

Karpe, F. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00548.x · Cited by 360 · see citing works

Relation of Lipoprotein Subclasses as Measured by Proton Nuclear Magnetic Resonance Spectroscopy to Coronary Artery Disease

Freedman, D. S., Otvos, J. D., Jeyarajah, E. J., Barboriak, J. J., Anderson, A. J., & Walker, J. A. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.7.1046 · Cited by 345 · see citing works

Apolipoprotein A-V

van der Vliet, H. N., Groenink, M., Leegwater, A. C. J., Levels, J. H. M., Reitsma, P. H., BOERS, W., & Chamuleau, R. A. F. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106888200 · Cited by 344 · see citing works

ApoAV Reduces Plasma Triglycerides by Inhibiting Very Low Density Lipoprotein-Triglyceride (VLDL-TG) Production and Stimulating Lipoprotein Lipase-mediated VLDL-TG Hydrolysis

Schaap, F. G., Rensen, P. C. N., Voshol, P. J., Vrins, C. L. J., van der Vliet, H. N., Chamuleau, R. A. F. M., Havekes, L. M., Groen, A. K., & van Dijk, K. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403240200 · Cited by 300 · see citing works

Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study

McNamara, J. R. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00484-6 · Cited by 278 · see citing works

Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia.

Li, W. W., Dammerman, M. M., Smith, J. D., Metzger, S., Breslow, J. L., & Leff, T. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118324 · Cited by 278 · see citing works

p53 Website and analysis of p53 gene mutations in human cancer: Forging a link between epidemiology and carcinogenesis

Soussi, T., Dehouche, K., & Béroud, C. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200001)15:1 · Cited by 269 · see citing works

Lipoprotein lipase: the regulation of tissue specific expression and its role in lipid and energy metabolism

Preiss-Landl, K., Zimmermann, R., Hämmerle, G., & Zechner, R. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200210000-00002 · Cited by 240 · see citing works

Postprandial lipemia: the origin of an early peak studied by specific dietary fatty acid intake during sequential meals

Fielding, B., Callow, J., Owen, R., Samra, J. S., Dr, M., & Frayn, K. N. (1996) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/63.1.36 · Cited by 224 · see citing works

Apolipoprotein A5, a Crucial Determinant of Plasma Triglyceride Levels, Is Highly Responsive to Peroxisome Proliferator-activated Receptor α Activators

Vu‐Dac, N., Gervois, P. P., Jäkel, H., Nowak, M., Baugé, E., Dehondt, H., Staels, B., Pennacchio, L. A., Rubin, E. M., Fruchart‐Najib, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212191200 · Cited by 206 · see citing works

Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5

Fruchart‐Najib, J., Baugé, E., Niculescu, L. S., Pham, T., Thomas, B., Rommens, C., Majd, Z., Brewer, B., Pennacchio, L. A., & Fruchart, J. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.003 · Cited by 198 · see citing works

The Human Apolipoprotein AV Gene Is Regulated by Peroxisome Proliferator-activated Receptor-α and Contains a Novel Farnesoid X-activated Receptor Response Element

Prieur, X., Coste, H., & Rodríguez, J. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301302200 · Cited by 194 · see citing works

Long- and short-term risk of sudden coronary death.

Cupples, L. A., GAGNON, D. R., & Wb, K. (1992) · PubMed · Cited by 191 · see citing works

Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100.

Campos, E. M., Nakajima, K., Tanaka, A., & Havel, R. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41527-5 · Cited by 185 · see citing works

Effect of feeding and obesity on lipoprotein lipase activity, immunoreactive protein, and messenger RNA levels in human adipose tissue.

Ong, J. M., & Kern, P. A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114155 · Cited by 158 · see citing works

Structure and Interfacial Properties of Human Apolipoprotein A-V

Weinberg, R. B., Cook, V. R., Beckstead, J. A., Martin, D. D. O., Gallagher, J. W., Shelness, G. S., & Ryan, R. O. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303784200 · Cited by 155 · see citing works

A risk factor for atherosclerosis: triglyceride-rich lipoproteins.

Mj, M., & Jp, K. (2001) · PubMed · Cited by 141 · see citing works

The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore

Lai, C., Tai, E. S., Tan, C. E., Cutter, J. L., Chew, S. K., Zhu, Y., Adiconis, X., & Ordovás, J. M. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300251-jlr200 · Cited by 137 · see citing works

The genetic effect of the apoprotein AV gene on the serum triglyceride level in Japanese

Nabika, T., Nasreen, S., Kobayashi, S., & Masuda, J. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00252-6 · Cited by 135 · see citing works

Triglycerides and atherogenic lipoproteins: rationale for lipid management

Krauss, R. M. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00213-7 · Cited by 135 · see citing works

Elevated Remnant-Like Particle Cholesterol and Triglyceride Levels in Diabetic Men and Women in the Framingham Offspring Study

Schaefer, E. J., McNamara, J. R., Shah, P. K., Nakajima, K., Cupples, L. A., Ordovás, J. M., & Wilson, P. W. F. (2002) · Diabetes Care · doi:10.2337/diacare.25.6.989 · Cited by 134 · see citing works

Newly Identified Apolipoprotein AV Gene Predisposes to High Plasma Triglycerides in Familial Combined Hyperlipidemia

Ribalta, J., Figuera, L., Fernandez-Ballart, J. D., Vilella, E., Cabezas, M. C., Masana, L., & Joven, J. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.9.1597 · Cited by 131 · see citing works

Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildren

Endo, K., Yanagi, H., Araki, J., Hirano, C., Yamakawa‐Kobayashi, K., & Tomura, S. (2002) · Human Genetics · doi:10.1007/s00439-002-0825-0 · Cited by 123 · see citing works

Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges

Martin, S., Nicaud, V., Humphries, S. E., & Talmud, P. J. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(03)00033-4 · Cited by 119 · see citing works

Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids

Aouizerat, B. E., Kulkarni, M. V., Heilbron, D. C., Drown, D. J., Raskin, S., Pullinger, C. R., Malloy, M. J., & Kane, J. P. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200480-jlr200 · Cited by 118 · see citing works

Linkage and Association Between Distinct Variants of the APOA1/C3/A4/A5 Gene Cluster and Familial Combined Hyperlipidemia

Eichenbaum‐Voline, S., Olivier, M., Jones, E. L., Naoumova, R. P., Jones, B., Gau, B. C., Patel, H., Seed, M., Betteridge, D. J., Galton, D. J., et al. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000099881.83261.d4 · Cited by 105 · see citing works

Remnant lipoprotein cholesterol and triglyceride reference ranges from the Framingham Heart Study

McNamara, J. R., Shah, P. K., Nakajima, K., Cupples, L. A., Wilson, P. W. F., Ordovás, J. M., & Schaefer, E. J. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.6.1224 · Cited by 105 · see citing works

Association of the APOLIPOPROTEIN A1/C3/A4/A5 Gene Cluster With Triglyceride Levels and LDL Particle Size in Familial Combined Hyperlipidemia

Mar, R., Pajukanta, P., Allayee, H., Groenendijk, M., Dallinga‐Thie, G. M., Krauss, R. M., Sinsheimer, J. S., Cantor, R. M., de Bruin, T. W., & Lusis, A. J. (2004) · Circulation Research · doi:10.1161/01.res.0000124922.61830.f0 · Cited by 101 · see citing works

The −1131T→C polymorphism in the apolipoprotein A5 gene is associated with postprandial hypertriacylglycerolemia; elevated small, dense LDL concentrations; and oxidative stress in nonobese Korean men

Jang, Y., Kim, J. Y., Kim, O. Y., Lee, J. E., Cho, H., Ordovás, J. M., & Lee, J. H. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.4.832 · Cited by 97 · see citing works

Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11

Olivier, M., Wang, X., Cole, R., Gau, B. C., Kim, J. J., Rubin, E. M., & Pennacchio, L. A. (2004) · Genomics · doi:10.1016/j.ygeno.2003.11.016 · Cited by 90 · see citing works

The familial periodic paralyses and nondystrophic myotonias

Ptáček, L. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00123-5 · Cited by 82 · see citing works

Analysis of Apolipoprotein A5, C3, and Plasma Triglyceride Concentrations in Genetically Engineered Mice

Baroukh, N., Baugé, E., Akiyama, J. A., Chang, J. J. ‐., Afzal, V., Fruchart, J., Rubin, E. M., Fruchart‐Najib, J., & Pennacchio, L. A. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000130463.68272.1d · Cited by 81 · see citing works

Nutritional regulation of lipoprotein lipase in guinea pig tissues

Semb, H., & Olivecrona, T. (1986) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(86)90281-x · Cited by 61 · see citing works

Plasma remnant-like particle lipid and apolipoprotein levels in normolipidemic and hyperlipidemic subjects

Marcoux, C., Tremblay, M., Fredenrich, A., Jacques, H., Krimbou, L., Nakajima, K., Davignon, J., & Cohn, J. S. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00042-2 · Cited by 57 · see citing works

The effects of scale: variation in the APOA1/C3/A4/A5 gene cluster

Fullerton, S., Buchanan, A., Sonpar, V. A., Taylor, S. L., Smith, J. D., Carlson, C., Salomaa, V., Stengård, J., Boerwinkle, E., Clark, A., et al. (2004) · Human Genetics · doi:10.1007/s00439-004-1106-x · Cited by 56 · see citing works

Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment.

Karpe, F. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00700-0 · Cited by 50 · see citing works

Triglycerides: risk factor or fellow traveler?

Forrester, J. S. (2001) · Current Opinion in Cardiology · doi:10.1097/00001573-200107000-00007 · Cited by 40 · see citing works

Association of remnant-like particle cholesterol with coronary artery disease in patients with normal total cholesterol levels

Masuoka, H., Kamei, S., Wagayama, H., Ozaki, M., Kawasaki, A., Tanaka, T., Kitamura, M., Katoh, S., Shintani, U., Misaki, M., et al. (2000) · American Heart Journal · doi:10.1016/s0002-8703(00)90240-0 · Cited by 40 · see citing works

The Apolipoprotein AV Gene and Diurnal Triglyceridaemia in Normolipidaemic Subjects

Masana, L., Ribalta, J., Salazar, J., Fernandez-Ballart, J. D., Joven, J., & Cabezas, M. C. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.078 · Cited by 39 · see citing works

Properties of triglyceride-rich and cholesterol-rich lipoproteins in the remnant-like particle fraction of human blood plasma

Campos, E. M., Kotite, L., Blanche, P. J., Mitsugi, Y., Frost, P. H., Masharani, U. B., Krauss, R. M., & Havel, R. J. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30142-5 · Cited by 28 · see citing works

Haplotypes in the APOA1-C3-A4-A5 gene cluster affect plasma lipids in both humans and baboons

Wang, Q. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh121 · Cited by 28 · see citing works

Genetic heterogeneity in the apolipoprotein C-III promoter and effects of insulin

Dallinga‐Thie, G. M., Groenendijk, M., Blom, R. N. H. H. C., de Bruin, T. W., & de Kant, E. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30278-9 · Cited by 27 · see citing works

Plasma triglyceride-rich lipoprotein remnants as a risk factor of ‘Pokkuri disease’

Takeichi, S., Nakajima, Y., Yukawa, N., Saito, T., Seto, Y., Huang, X.-L., Kusakabe, T., Jin, Z.-B., Hasegawa, I., Nakano, T., et al. (2001) · Legal Medicine · doi:10.1016/s1344-6223(01)00010-4 · Cited by 25 · see citing works

Allele-specific Differences in Apolipoprotein C-III mRNA Expression in Human Liver

Esterbauer, H., Hell, E., Krempler, F., & Patsch, W. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.3.331 · Cited by 23 · see citing works

Remnant-Like Particle Cholesterol Levels in Korean Patients with Coronary Artery Disease and Non-Insulin Dependent Diabetes Mellitus

Song, J., Park, H., Hong, S. H., Lee, H. K., Park, Y. B., & Kim, J. Q. (2000) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2000.062 · Cited by 9 · see citing works

Triglycerides and the Risk of Coronary Heart Disease: 10 158 Incident Cases Among 262 525 Participants in 29 Western Prospective Studies

Sarwar, N., Danesh, J., Eiriksdottir, G., Sigurdsson, G., Wareham, N., Bingham, S., Boekholdt, S. M., Khaw, K.-T., & Gudnason, V. (2007) · Circulation · doi:10.1161/circulationaha.106.637793 · Cited by 1,408 · see citing works

Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction

Jørgensen, A. B., Frikke-Schmidt, R., West, A. S., Grande, P., Nordestgaard, B. G., & Tybjærg-Hansen, A. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs431 · Cited by 501 · see citing works

A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study

Kathiresan, S., Manning, A. K., Demissie, S., D’Agostino, R. B., Surti, A., Guiducci, C., Gianniny, L., Burtt, N. P., Melander, O., Orho‐Melander, M., et al. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-s1-s17 · Cited by 341 · see citing works

Common Missense Variant in the Glucokinase Regulatory Protein Gene Is Associated With Increased Plasma Triglyceride and C-Reactive Protein but Lower Fasting Glucose Concentrations

Orho‐Melander, M., Melander, O., Guiducci, C., Pérez‐Martínez, P., Corella, D., Roos, C., Tewhey, R., Rieder, M. J., Hall, J. L., Abecasis, G. R., et al. (2008) · Diabetes · doi:10.2337/db08-0516 · Cited by 301 · see citing works

Apolipoprotein AV Accelerates Plasma Hydrolysis of Triglyceriderich Lipoproteins by Interaction with Proteoglycan-bound Lipoprotein Lipase

Merkel, M., Loeffler, B., Kluger, M. A., Fabig, N., Geppert, G., Pennacchio, L. A., Laatsch, A., & Heeren, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411412200 · Cited by 292 · see citing works

Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease

Rosenson, R. S., Davidson, M. H., Hirsh, B. J., Kathiresan, S., & Gaudet, D. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.042 · Cited by 260 · see citing works

The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reports

Cupples, L. A., Arruda, H. T., Benjamin, E. J., D’Agostino, R. B., Demissie, S., DeStefano, A. L., Dupuis, J., Falls, K. M., Fox, C. S., Gottlieb, D. J., et al. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-s1-s1 · Cited by 212 · see citing works

CLOCK genetic variation and metabolic syndrome risk: modulation by monounsaturated fatty acids

Garaulet, M., Lee, Y.-C., Shen, J., Parnell, L. D., Arnett, D. K., Tsai, M. Y., Lai, C.-Q., & Ordovas, J. M. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27536 · Cited by 172 · see citing works

FTO Genotype and 2-Year Change in Body Composition and Fat Distribution in Response to Weight-Loss Diets

Zhang, X., Qi, Q., Zhang, C., Smith, S. R., Hu, F. B., Sacks, F. M., Bray, G. A., & Qi, L. (2012) · Diabetes · doi:10.2337/db11-1799 · Cited by 163 · see citing works

The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk

Lai, C., Parnell, L. D., & Ordovás, J. M. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000162320.54795.68 · Cited by 137 · see citing works

Genetic determinants of inherited susceptibility to hypercholesterolemia – a comprehensive literature review

Paththinige, C. S., Sirisena, N. D., & Dissanayake, V. H. W. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0488-4 · Cited by 124 · see citing works

Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: A systematic in-depth review

Boes, E., Coassin, S., Kollerits, B., Heid, I. M., & Kronenberg, F. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.11.003 · Cited by 121 · see citing works

Fenofibrate Effect on Triglyceride and Postprandial Response of Apolipoprotein A5 Variants

Lai, C., Arnett, D. K., Corella, D., Straka, R. J., Tsai, M. Y., Peacock, J. M., Adiconis, X., Parnell, L. D., Hixson, J. E., Province, M. A., et al. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.140103 · Cited by 119 · see citing works

Dietary Intake of n-6 Fatty Acids Modulates Effect of Apolipoprotein A5 Gene on Plasma Fasting Triglycerides, Remnant Lipoprotein Concentrations, and Lipoprotein Particle Size

Lai, C., Corella, D., Demissie, S., Cupples, L. A., Adiconis, X., Zhu, Y., Parnell, L. D., Tucker, K. L., & Ordovás, J. M. (2006) · Circulation · doi:10.1161/circulationaha.105.577296 · Cited by 117 · see citing works

Apolipoprotein A-V; a potent triglyceride reducer

Nilsson, S. K., Heeren, J., Olivecrona, G., & Merkel, M. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.07.019 · Cited by 115 · see citing works

APOA5 gene variation modulates the effects of dietary fat intake on body mass index and obesity risk in the Framingham Heart Study

Corella, D., Lai, C., Demissie, S., Cupples, L. A., Manning, A. K., Tucker, K. L., & Ordovás, J. M. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0147-0 · Cited by 109 · see citing works

APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency

Calandra, S., Oliva, C. P., Tarugi, P., & Bertolini, S. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000217892.00618.54 · Cited by 103 · see citing works

Apolipoprotein A-V Interaction with Members of the Low Density Lipoprotein Receptor Gene Family

Nilsson, S. K., Lõokene, A., Beckstead, J. A., Gliemann, J., Ryan, R. O., & Olivecrona, G. (2007) · Biochemistry · doi:10.1021/bi7000533 · Cited by 102 · see citing works

Genetic variants in human CLOCK associate with total energy intake and cytokine sleep factors in overweight subjects (GOLDN population)

Garaulet, M., Lee, Y.-C., Shen, J., Parnell, L. D., Arnett, D. K., Tsai, M. Y., Lai, C.-Q., & Ordovas, J. M. (2010) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.176 · Cited by 101 · see citing works

Genetic and nutrient determinants of the metabolic syndrome

Phillips, C. M., López‐Miranda, J., Pérez‐Jiménez, F., McManus, R., & Roche, H. M. (2006) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000221579.25878.11 · Cited by 100 · see citing works

A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A-V concentration

Ishihara, M., Kujiraoka, T., Iwasaki, T., Nagano, M., Takano, M., Ishii, J., Tsuji, M., Ide, H., Miller, I. P., Miller, N. E., et al. (2005) · Journal of Lipid Research · doi:10.1194/jlr.d500018-jlr200 · Cited by 97 · see citing works

Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population Study

Vaessen, S. F. C., Schaap, F. G., Kuivenhoven, J. A., Groen, A. K., Hutten, B. A., Boekholdt, S. M., Hattori, H., Sandhu, M. S., Bingham, S. A., Luben, R., et al. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600233-jlr200 · Cited by 93 · see citing works

Thyroid Hormone Regulates the Hypotriglyceridemic Gene APOA5

Prieur, X., Huby, T., Coste, H., Schaap, F. G., Chapman, M. J., & Rodríguez, J. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503139200 · Cited by 83 · see citing works

Susceptibility loci for metabolic syndrome and metabolic components identified in Han Chinese: a multi‐stage genome‐wide association study

Zhu, Y., Zhang, D., Zhou, D., Li, Z., Li, Z., Fang, L., Yang, M., Shan, Z., Li, H., Chen, J., et al. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13042 · Cited by 80 · see citing works

The paradox of ApoA5 modulation of triglycerides: Evidence from clinical and basic research

Garelnabi, M., Lor, K., Jin, J., Chai, F., & Santanam, N. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.09.007 · Cited by 78 · see citing works

Evidence for Consistent Intragenic and Intergenic Interactions between SNP Effects in the APOA1/C3/A4/A5 Gene Cluster

Hamon, S., Kardia, S. L. R., Boerwinkle, E., Liu, K., Klos, K. L. E., Clark, A. G., & Sing, C. F. (2006) · Human Heredity · doi:10.1159/000093384 · Cited by 77 · see citing works

A genome-wide association and gene–environment interaction study for serum triglycerides levels in a healthy Chinese male population

Tan, A., Sun, J., Xia, N., Qin, X. Y., Hu, Y., Zhang, S., Tao, S., Gao, Y., Yang, X., Zhang, H., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr587 · Cited by 77 · see citing works

APOA5 variants and metabolic syndrome in Caucasians

Grallert, H., Sedlmeier, E., Huth, C., Kolz, M., Heid, I. M., Meisinger, C., Herder, C., Straßburger, K., Gehringer, A., Haak, M., et al. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700011-jlr200 · Cited by 75 · see citing works

Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan

Hsu, L., Ko, Y., Chang, C., Hu, C.-F., Wu, S., Teng, M., Wang, C., Ho, W., Ko, Y.-S., Hsu, T., et al. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.05.031 · Cited by 74 · see citing works

Variants at the APOA5 locus, association with carotid atherosclerosis, and modification by obesity: the Framingham Study

Elosúa, R., Ordovás, J. M., Cupples, L. A., Lai, C., Demissie, S., Fox, C. S., Polak, J. F., Wolf, P. A., D’Agostino, R. B., & O’Donnell, C. J. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m500446-jlr200 · Cited by 71 · see citing works

The −1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study

Martinelli, N., Trabetti, E., Bassi, A., Girelli, D., Friso, S., Pizzolo, F., Sandri, M. F., Malerba, G., Pignatti, P. F., Corrocher, R., et al. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.04.009 · Cited by 68 · see citing works

Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes

Qi, L., Liu, S., Rifai, N., Hunter, D., & Hu, F. B. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.05.006 · Cited by 67 · see citing works

Association of Blood Lipids With Common DNA Sequence Variants at 19 Genetic Loci in the Multiethnic United States National Health and Nutrition Examination Survey III

Keebler, M., Sanders, C., Surti, A., Guiducci, C., Burtt, N. P., & Kathiresan, S. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.108.829473 · Cited by 62 · see citing works

APOE/C1/C4/C2 Gene Cluster Genotypes, Haplotypes and Lipid Levels in Prospective Coronary Heart Disease Risk Among UK Healthy Men

Ken‐Dror, G., Talmud, P. J., Humphries, S. E., & Drenos, F. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00044 · Cited by 61 · see citing works

The PLIN4 Variant rs8887 Modulates Obesity Related Phenotypes in Humans through Creation of a Novel miR-522 Seed Site

Richardson, K., Louie‐Gao, Q., Arnett, D. K., Parnell, L. D., Lai, C., Dávalos, A., Fox, C. S., Demissie, S., Cupples, L. A., Fernandez-Hernando, C. F., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017944 · Cited by 60 · see citing works

APOA5 genotype modulates 2-y changes in lipid profile in response to weight-loss diet intervention: the Pounds Lost Trial

Zhang, X., Qi, Q., Bray, G. A., Hu, F. B., Sacks, F. M., & Qi, L. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.040907 · Cited by 60 · see citing works

Apolipoprotein A5 Gene Promoter Region T-1131C Polymorphism Associates With Elevated Circulating Triglyceride Levels and Confers Susceptibility for Development of Ischemic Stroke

Havasi, V., Szolnoki, Z., Talián, G. C., Bene, J., Komlósi, K., Maász, A., Somogyvári, F., Kondacs, A., Szabó, M., Fodor, L., et al. (2006) · Journal of Molecular Neuroscience · doi:10.1385/jmn:29:2:177 · Cited by 59 · see citing works

Apolipoprotein A5 and triglyceridemia. Focus on the effects of the common variants

Hubacek, J. A. (2005) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2005.153 · Cited by 59 · see citing works

Multiple genetic variants along candidate pathways influence plasma high-density lipoprotein cholesterol concentrations

Lu, Y., Dollé, M. E. T., Imholz, S., Slot, R. V. ‘., Verschuren, W. M. M., Wijmenga, C., Feskens, E. J. M., & Boer, J. M. A. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800232-jlr200 · Cited by 56 · see citing works

APOC3/A5 haplotypes, lipid levels, and risk of myocardial infarction in the Central Valley of Costa Rica

Ruiz-Narváez, E., Yang, Y., Nakanishi, Y., Kirchdorfer, J., & Campos, H. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500040-jlr200 · Cited by 57 · see citing works

Epigenome-wide association study of triglyceride postprandial responses to a high-fat dietary challenge

Lai, C., Wojczynski, M. K., Parnell, L. D., Hidalgo, B., Irvin, M. R., Aslibekyan, S. W., Province, M. A., Absher, D., Arnett, D. K., & Ordovás, J. M. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m069948 · Cited by 57 · see citing works

APOA5 polymorphisms influence plasma triglycerides in young, healthy African Americans and whites of the CARDIA Study

Klos, K. L. E., Hamon, S., Clark, A. G., Boerwinkle, E., Liu, K., & Sing, C. F. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400437-jlr200 · Cited by 53 · see citing works

The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: Association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease

Jang, Y., Paik, J. K., Hyun, Y. J., Chae, J. S., Kim, J. Y., Choi, J. R., Lee, S., Shin, D.-J., Ordovás, J. M., & Lee, J. H. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.12.024 · Cited by 52 · see citing works

Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the Genetics of Lipid-Lowering Drugs and Diet Network study

Liu, Y., Ordovás, J. M., Gao, G., Province, M. A., Straka, R. J., Tsai, M. Y., Lai, C., Zhang, K., Borecki, I. B., Hixson, J. E., et al. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32831e030e · Cited by 52 · see citing works

Interactions of the Apolipoprotein A5 Gene Polymorphisms and Alcohol Consumption on Serum Lipid Levels

Yin, R., Li, Y., Liu, W., Zhang, L., & Wu, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017954 · Cited by 50 · see citing works

Apoprotein A‐V: An important regulator of triglyceride metabolism

Kluger, M. A., Heeren, J., & Merkel, M. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-0863-4 · Cited by 50 · see citing works

Two Independent Apolipoprotein A5 Haplotypes Modulate Postprandial Lipoprotein Metabolism in a Healthy Caucasian Population

Moreno‐Luna, R., Pérez‐Jiménez, F., Marı́n, C., Pérez‐Martínez, P., Gómez, P., Jiménez, Y., Delgado‐Lista, J., Moreno, J. A., Tanaka, T., Ordovás, J. M., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1802 · Cited by 48 · see citing works

Strong association of the APOA5-1131T>C gene variant and early-onset acute myocardial infarction

Caterina, R. D., Talmud, P. J., Merlini, P. A., Foco, L., Pastorino, R., Altshuler, D., Mauri, F., Peyvandi, F., Lina, D., Kathiresan, S., et al. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.11.011 · Cited by 47 · see citing works

Analysis of common and coding variants with cardiovascular disease in the diabetes heart study

Adams, J. N., Raffield, L. M., Freedman, B. I., Langefeld, C. D., Ng, M. C. Y., Carr, J. J., Cox, A. J., & Bowden, D. W. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-77 · Cited by 45 · see citing works

Apolipoprotein A5 Gene IVS3+G476A Allelic Variant Confers Susceptibility for Development of Ischemic Stroke

Maász, A., Kisfali, P., Járomi, L., Horvatovich, K., Szolnoki, Z., Csöngei, V., Sáfrány, E., Sipeky, C., Hadarits, F., & Melegh, B. (2008) · Circulation Journal · doi:10.1253/circj.72.1065 · Cited by 44 · see citing works

Fenofibrate and metabolic syndrome

T. Kraja, A., A. Province, M., J. Straka, R., M. Ordovas, J., B. Borecki, I., & K. Arnett, D. (2010) · Endocrine, Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153010791213047 · Cited by 40 · see citing works

Is apolipoprotein A5 a novel regulator of triglyceride‐rich lipoproteins?

Jäkel, H., Nowak, M., Helleboid‐Chapman, A., Fruchart‐Najib, J., & Fruchart, J. (2006) · Annals of Medicine · doi:10.1080/07853890500407488 · Cited by 40 · see citing works

Impact of Apolipoprotein A5 Variants on Statin Treatment Efficacy

Hubacek, J. A., Adámková, V., Prusíková, M., Šnejdrlová, M., Hirschfeldová, K., Lánská, V., Češka, R., & Vrablı́k, M. (2009) · Pharmacogenomics · doi:10.2217/pgs.09.17 · Cited by 39 · see citing works

Influence of apolipoprotein A-V on the metabolic fate of triacylglycerol

Sharma, V., Forte, T. M., & Ryan, R. O. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32835c8c1a · Cited by 39 · see citing works

Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia

Smith, R. C., Segman, R. H., Golcer-Dubner, T., Павлов, В. Н., & Lerer, B. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500474 · Cited by 39 · see citing works

Gender-modulated impact of apolipoprotein A5 gene (APOA5) −1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults

Kömürcü-Bayrak, E., Onat, A., Poda, M., Humphries, S. E., Palmen, J., Güçlü-Geyik, F., Can, G., & Erginel‐Ünaltuna, N. (2008) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2008.161 · Cited by 38 · see citing works

Apolipoprotein B genetic variants modify the response to fenofibrate: a GOLDN study

Wojczynski, M. K., Gao, G., Borecki, I. B., Hopkins, P. N., Parnell, L. D., Lai, C., Ordovás, J. M., Chung, B. H., & Arnett, D. K. (2010) · Journal of Lipid Research · doi:10.1194/jlr.p001834 · Cited by 38 · see citing works

Different effects of apolipoprotein A5 SNPs and haplotypes on triglyceride concentration in three ethnic origins

Ken‐Dror, G., Goldbourt, U., & Dankner, R. S. (2010) · Journal of Human Genetics · doi:10.1038/jhg.2010.27 · Cited by 37 · see citing works

Strong Linkage Disequilibrium and Association of -1131T>C and c.553G>T Polymorphisms of the Apolipoprotein A5 Gene With Hypertriglyceridemia in a Japanese Population

Matsunaga, A., Arishima, H., Niimura, H., Zhang, B., Uehara, Y., Ohwaki, K., Morita, M., Hayashida, K., & Saku, K. (2007) · Circulation Journal · doi:10.1253/circj.71.746 · Cited by 36 · see citing works

Gene–Nutrient Interactions in the Metabolic Syndrome

Phillips, C. M., Tierney, A. C., & Roche, H. M. (2008) · Lifestyle Genomics · doi:10.1159/000112461 · Cited by 36 · see citing works

Apolipoprotein A-V: a potential modulator of plasma triglyceride levels in Turks

Hodoğlugil, U., Tanyolaç, S., Williamson, D. W., Huang, Y., & Mahley, R. W. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500343-jlr200 · Cited by 37 · see citing works

Apolipoprotein A5 gene C56G variant confers risk for the development of large-vessel associated ischemic stroke

Maász, A., Kisfali, P., Szolnoki, Z., Hadarits, F., & Melegh, B. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0768-z · Cited by 38 · see citing works

The Role of Triglyceride-rich Lipoproteins and Their Remnants in Atherosclerotic Cardiovascular Disease

Gabani, M. H., Shapiro, M. D., & Toth, P. P. (2023) · European Cardiology Review · doi:10.15420/ecr.2023.16 · Cited by 38 · see citing works

Influence of apoA-V gene variants on postprandial triglyceride metabolism: impact of gender

Olano-Martin, E., Abraham, E. C., Gill-Garrison, R., Valdes, A. M., Grimaldi, K. A., Tang, F., Jackson, K. G., Williams, C. M., & Minihane, A. M. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m700112-jlr200 · Cited by 34 · see citing works

Apolipoprotein A5 polymorphisms and risk of coronary artery disease: A meta-analysis

Zhang, Z., Peng, B., Gong, R.-R., Gao, L., Du, J., Fang, D., Song, Y., Li, Y., & Ou, G. (2011) · BioScience Trends · doi:10.5582/bst.2011.v5.4.165 · Cited by 34 · see citing works

Association of APOA5 rs662799 and rs3135506 polymorphisms with arterial hypertension in Moroccan patients

Ouatou, S., Ajjemami, M., Charoute, H., Sefri, H., Ghalim, N., Rhaissi, H., Benrahma, H., Barakat, A., & Rouba, H. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-60 · Cited by 34 · see citing works

Association between lipoproteins and telomere length in US adults: data from the NHANES 1999–2002

Yun-fen, C., Zhou, K.-W., Yang, G., & Chen, C. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1030-7 · Cited by 34 · see citing works

Admixture mapping of quantitative trait loci for blood lipids in African-Americans.

Basu, A., Tang, H., Lewis, C., North, K., Curb, J., Quertermous, T., Mosley, T., Boerwinkle, E., Zhu, X.-F., & Risch, N. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp122 · Cited by 31 · see citing works

Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study

Hallman, D. M., Srinivasan, S. R., Chen, W., Boerwinkle, E., & Berenson, G. S. (2006) · Metabolism · doi:10.1016/j.metabol.2006.07.018 · Cited by 32 · see citing works

Nutrigenomics: a case for the common soil between cardiovascular disease and cancer

Iacoviello, L., Santimone, I., Latella, M. C., de Gaetano, G., & Donati, M. B. (2008) · Genes & Nutrition · doi:10.1007/s12263-008-0079-0 · Cited by 32 · see citing works

Apolipoprotein A5 IVS3+476A Allelic Variant Associates With Increased Trigliceride Levels and Confers Risk for Development of Metabolic Syndrome in Hungarians

Kisfali, P., Mohás, M., Maász, A., Hadarits, F., Markó, L., Horvatovich, K., Oroszlán, T., Bagosi, Z., Bujtor, Z., Gasztonyi, B., et al. (2007) · Circulation Journal · doi:10.1253/circj.72.40 · Cited by 31 · see citing works

APOA5 variants predispose hyperlipidemic patients to atherogenic dyslipidemia and subclinical atherosclerosis

Guardiola, M., Cofán, M., de Castro-Orós, I., Cenarro, A., Plana, N., Talmud, P. J., Masana, L., Ros, E., Civeira, F., & Ribalta, J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.03.008 · Cited by 31 · see citing works

Early Subclinical Atherosclerosis in Gestational Diabetes: The Predictive Role of Routine Biomarkers and Nutrigenetic Variants

Franzago, M., Fraticelli, F., Nicola, M. D., Bianco, F., Marchetti, D., Celentano, C., Liberati, M., Caterina, R. D., Stuppia, L., & Vitacolonna, E. (2018) · Journal of Diabetes Research · doi:10.1155/2018/9242579 · Cited by 31 · see citing works

Homozygosity for a partial deletion of apoprotein A-V signal peptide results in intracellular missorting of the protein and chylomicronemia in a breast-fed infant

Albers, K., Schlein, C., Wenner, K., Lohse, P., Bartelt, A., Heeren, J., Santer, R., & Merkel, M. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.12.009 · Cited by 30 · see citing works

A single nucleotide polymorphism in APOA5 determines triglyceride levels in Hong Kong and Guangzhou Chinese

Jiang, C. Q., Liu, B., Cheung, B. M. Y., Lam, T. H., Lin, J. M., Jin, Y. L., Yue, X. J., Ong, K. L., Tam, S., Wong, K. S., et al. (2010) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.93 · Cited by 30 · see citing works

The association of common genetic variants in the APOA5, LPL and GCK genes with longitudinal changes in metabolic and cardiovascular traits

Webster, R. J., Warrington, N. M., Weedon, M. N., Hattersley, A. T., McCaskie, P. A., Beilby, J. P., Palmer, L. J., & Frayling, T. M. (2008) · Diabetologia · doi:10.1007/s00125-008-1175-9 · Cited by 30 · see citing works

Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome

Niculescu, L. S., Fruchart‐Najib, J., Fruchart, J., & Sima, A. V. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.257 · Cited by 29 · see citing works

The influence of the S19W SNP of the APOA5 gene on triglyceride levels in southern Brazil: Interactions with the APOE gene, sex and menopause status

de Andrade, F. M., Maluf, S. W., Schuch, J. B., Voigt, F., Barros, A. C., Lucatelli, J. F., & Hutz, M. H. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.12.013 · Cited by 27 · see citing works

Contribution of APOA5−1131C allele to the increased susceptibility of diabetes mellitus in association with higher triglyceride in Korean women

Lee, K., Kim, O. Y., Lim, H. H., Lee, Y. J., Jang, Y., & Lee, J. H. (2010) · Metabolism · doi:10.1016/j.metabol.2010.02.008 · Cited by 26 · see citing works

Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia

van der Vleuten, G. M., Isaacs, A. J., Zeng, W., ter Avest, E., Talmud, P. J., Dallinga‐Thie, G. M., van Duijn, C. M., Stalenhoef, A. F. H., & Graaf, J. D. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.10.012 · Cited by 26 · see citing works

Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome

Niculescu, L. S., Vladica, M., & Sima, A. V. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.11.103 · Cited by 25 · see citing works

Influences of APOA5 Variants on Plasma Triglyceride Levels in Uyghur Population

Li, S., Hu, B., Wang, Y., Wu, D., Li, J., & Wang, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110258 · Cited by 24 · see citing works

Apolipoprotein A5 and Lipoprotein Lipase Interact to Modulate Anthropometric Measures in Hispanics of Caribbean Origin

Smith, C. E., Tucker, K. L., Lai, C., Parnell, L. D., Lee, Y., & Ordovás, J. M. (2009) · Obesity · doi:10.1038/oby.2009.216 · Cited by 23 · see citing works

Apolipoprotein Polymorphisms and Familial Hypercholesterolemia

Dedoussis, G. V. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.9.1179 · Cited by 23 · see citing works

Increased concentrations of circulating vitamin E in carriers of the apolipoprotein A5 gene −1131T>C variant and associations with plasma lipids and lipid peroxidation

Sundl, I., Guardiola, M., Khoschsorur, G., Solà, R., Vallvé, J.-C., Godàs, G., Masana, L., Maritschnegg, M., Meinitzer, A., Cardinault, N., et al. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700285-jlr200 · Cited by 23 · see citing works

Genetic Regulatory Networks of Apolipoproteins and Associated Medical Risks

Basavaraju, P., Balasubramani, R., Kathiresan, D. S., Devaraj, I., Babu, K., Vasanthakumar, A., & Moorthi, P. V. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.788852 · Cited by 21 · see citing works

Associations between explorative dietary patterns and serum lipid levels and their interactions with ApoA5 and ApoE haplotype in patients with recently diagnosed type 2 diabetes

for the GDS Group, Weber, K. S., Knebel, B., Straßburger, K., Kotzka, J., Stehle, P., Szendroedi, J., Müssig, K., Buyken, A. E., & Roden, M. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0455-9 · Cited by 20 · see citing works

Sequence Analysis of APOA5 Among the Kuwaiti Population Identifies Association of rs2072560, rs2266788, and rs662799 With TG and VLDL Levels

Jasim, A. A., Al‐Bustan, S. A., Al-Kandari, W. Y., Al‐Serri, A., & Alaskar, H. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00112 · Cited by 20 · see citing works

Impact of genetic polymorphisms on the risk of lipid disorders in patients on anti-HIV therapy

Bonnet, É., Genoux, A., Bernard, J., Fauvel, J., Massip, P., & Perret, B. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.140 · Cited by 19 · see citing works

Association of apolipoprotein A5 gene polymorphisms and serum lipid levels

Li, Y.-Y., Yin, R.-X., Lai, C., Li, M., Long, X.-J., Li, K.-X., Liu, W.-Y., Zhang, L., & Wu, J.-Z. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.04.004 · Cited by 19 · see citing works

Interaction between APOA5 –1131T>C and APOE polymorphisms and their association with severe hypertriglyceridemia

Sousa, M. O., Alia, P. J., Pintó, X., Corbella, E., & Navarro, M.-Á. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.05.009 · Cited by 19 · see citing works

Multiple genetic determinants of plasma lipid levels in Caribbean Hispanics

Liao, Y., Lin, H., Rundek, T., Cheng, R., Hsi, E., Sacco, R. L., & Juo, S. H. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.11.011 · Cited by 19 · see citing works

Dietary fat and apolipoprotein genotypes modulate plasma lipoprotein levels in Brazilian elderly women

Paula, R., Souza, V. C., Benedet, A. L., de Souza, E. R., Toledo, J. O., Moraes, C. F., Gomes, L., Alho, C. S., Córdova, C., & Nóbrega, O. D. T. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0313-0 · Cited by 19 · see citing works

Genetically elevated levels of circulating triglycerides and brachial–ankle pulse wave velocity in a Chinese population

Yao, W.-M., Zhang, H.-F., Zhu, Z.-Y., Zhou, Y.-L., Liang, N.-X., Xu, D.-J., Zhou, F., Sheng, Y.-H., Yang, R., Gong, L., et al. (2012) · Journal of Human Hypertension · doi:10.1038/jhh.2012.23 · Cited by 19 · see citing works

Coronary heart disease and polymorphisms in genes affecting lipid metabolism and inflammation

Cambien, F. (2005) · Current Atherosclerosis Reports · doi:10.1007/s11883-005-0005-5 · Cited by 19 · see citing works

Validating a Rapid Method for Detecting Common Polymorphisms in the APOA5 Gene by Melting Curve Analysis Using LightTyper

Francès, F., Corella, D., Sorlí, J. V., Guillén, M., González, J. I., & Portolés, O. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.049676 · Cited by 18 · see citing works

Apolipoprotein A5 polymorphisms in Turkish population: association with serum lipid profile and risk of ischemic stroke

Demirdöğen, B. C., Şahin, E., Özçelik, A. T., Bek, S., Demirkaya, Ş., & Adalı, O. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1926-z · Cited by 18 · see citing works

Association between sequence variant of c.553 G > T in the apolipoprotein A5 gene and metabolic syndrome, insulin resistance, and carotid atherosclerosis

Chien, K., Hsu, H., Chen, Y., Su, T., Lee, Y., & Chen, M.-F. (2009) · Translational research · doi:10.1016/j.trsl.2009.06.005 · Cited by 18 · see citing works

Increased risk of obesity related to total energy intake with the APOA5-1131T > C polymorphism in Korean premenopausal women

Lim, H. H., Choi, M., Kim, J. Y., Lee, J. H., & Kim, O. Y. (2014) · Nutrition Research · doi:10.1016/j.nutres.2014.08.018 · Cited by 18 · see citing works

Apolipoprotein A5, a unique modulator of fasting and postprandial triglycerides

Zhang, L., Liu, M., Black, D. D., & Tso, P. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159185 · Cited by 17 · see citing works

APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease

Lee, K. W. J., Ayyobi, A. F., Frohlich, J. J., & Hill, J. S. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.04.024 · Cited by 82 · see citing works

Gender-modulated impact of apolipoprotein A5 gene (APOA5) −1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults

Kömürcü-Bayrak, E., Onat, A., Poda, M., Humphries, S. E., Palmen, J., Güçlü-Geyik, F., Can, G., & Erginel‐Ünaltuna, N. (2008) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2008.161 · Cited by 38 · see citing works

Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men

Dallongeville, J., Cottel, D., Montaye, M., Codron, V., Amouyel, P., & Helbecque, N. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.10.065 · Cited by 51 · see citing works

Gender-modulated impact of apolipoprotein A5 gene (APOA5)-1131T > C and c.56C > G polymorphisms on lipids, dyslipidernia and metabolic syndrome in Turkish adults

Komurcu-Bayrak, E., Onat, A., Poda, M., Humphries, S. E., Palmen, J., Guclu, F., Can, G., & Erginel‐Ünaltuna, N. (2008) · UCL Discovery (University College London)

Apolipoprotein A-V: a potential modulator of plasma triglyceride levels in Turks

Hodoğlugil, U., Tanyolaç, S., Williamson, D. W., Huang, Y., & Mahley, R. W. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500343-jlr200 · Cited by 37 · see citing works